Published in Ann Surg on December 01, 1997
The intraportal injection model: a practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer. BMC Cancer (2009) 0.92
Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer. World J Gastroenterol (2005) 0.88
Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases. Br J Cancer (2008) 0.85
The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients. Br J Cancer (2002) 0.84
Detection of disseminated tumor cells in nude mice with human gastric cancer. Clin Exp Metastasis (2003) 0.84
Significance of isolated tumor cells in lymph nodes among gastric cancer patients. J Cancer Res Clin Oncol (2004) 0.77
Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance. World J Gastrointest Oncol (2012) 0.75
Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary Adenocarcinoma. Tuberc Respir Dis (Seoul) (2013) 0.75
Tissue-type plasminogen activator activity in morphologically normal tissues adjacent to gastrointestinal carcinomas is associated with the degree of tumor progression. J Cancer Res Clin Oncol (2005) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med (1986) 17.64
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 9.73
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res (1986) 5.05
Gastric carcinoma. A pathobiological classification. Cancer (1977) 2.76
Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet (1994) 2.62
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet (1992) 2.21
The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis (1992) 1.86
Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays (1993) 1.67
Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer (1994) 1.39
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res (1994) 1.36
The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem (1986) 1.33
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol (1991) 1.33
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol (1992) 1.32
Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer (1991) 1.31
Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med (1995) 1.30
Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol (1996) 1.22
Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology (1989) 1.18
Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer (1994) 1.07
Defining the invasive phenotype of proximal gastric cancer cells. Cancer (1994) 1.04
Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res (1997) 0.97
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr Opin Immunol (1992) 0.97
Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. J Clin Oncol (1995) 0.97
Structure and function of the urokinase receptor. Blood Coagul Fibrinolysis (1993) 0.95
Tumor-cell dissociation at the invasion front: a new prognostic parameter in gastric cancer patients. Int J Cancer (1992) 0.93
Prognostic factors in stomach cancer surgery. Eur J Surg Oncol (1986) 0.91
Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin. Biochemistry (1985) 0.87
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene (2007) 10.79
Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet (1993) 3.45
ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr (2006) 3.36
Gender differences in long-term survival of patients with colorectal cancer. Br J Surg (2001) 3.18
Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol (1999) 2.62
E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res (1993) 2.55
Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood (1995) 2.20
Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer (1996) 2.06
Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol (1994) 1.90
De-novo expression of CD44 and survival in gastric cancer. Lancet (1993) 1.75
Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med (2000) 1.75
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene (2011) 1.75
Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol (1997) 1.73
Laparoscopic liver resection compared with conventional partial hepatectomy--a prospective analysis. Hepatogastroenterology (1999) 1.70
Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol (1995) 1.68
Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment. Cancer Biol Ther (2008) 1.66
Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene (2007) 1.62
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene (2011) 1.57
c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J Clin Oncol (2000) 1.54
Efficacy and tolerance of a new gentamicin collagen fleece (Septocoll) after surgical treatment of a pilonidal sinus. Colorectal Dis (2003) 1.51
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg (1996) 1.50
Nutritional intervention high in vitamins, protein, amino acids, and omega3 fatty acids improves protein metabolism during the hypermetabolic state after thermal injury. Arch Surg (2001) 1.49
Integrity and viability of homograft valves. Eur J Cardiothorac Surg (1994) 1.46
[Minimally invasive interventions in solitary liver cysts]. Chirurg (1992) 1.43
Perioperative mucosal pH and splanchnic endotoxin concentration in orthotopic liver transplantation. Br J Anaesth (1996) 1.41
Laparoscopic repair of traumatic diaphragmatic hernias. Surg Endosc (2000) 1.41
[The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI]. Zentralbl Chir (2010) 1.40
Prognostic factors in gastric cancer. Br J Surg (1997) 1.40
[Elective colon resection in Germany. A survey of the perioperative anesthesiological management]. Anaesthesist (2007) 1.39
[Carcinoid tumor of the stomach--aspects of surgical therapy]. Chirurg (1991) 1.39
Is radical scavenging necessary in the treatment of inflammatory bowel disease? Gastroenterology (1991) 1.39
[Ventilation in prone position in a 5-year-old child after multiple trauma. Effective treatment of persistent atelectasis]. Unfallchirurg (2000) 1.39
[Post-aggression metabolism: attempt at a status determination]. Infusionsther Transfusionsmed (1994) 1.39
Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group. Br J Surg (1994) 1.35
Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med (1995) 1.30
Laparoscopic creation of a loop colostomy. J Laparoendosc Surg (1991) 1.29
A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res (2001) 1.29
Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol (2000) 1.28
Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer (2007) 1.23
Effects of antacids on the clinical pharmacokinetics of drugs. An update. Clin Pharmacokinet (1990) 1.23
Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology (1997) 1.22
Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol (1996) 1.22
[Surgical techniques in hepatic resections: Ultrasonic aspirator versus Jet-Cutter. A prospective randomized clinical trial]. Zentralbl Chir (2001) 1.20
Regression of nonresectable inflammatory myofibroblastic tumours after treatment with nonsteroidal anti-inflammatory drugs. Eur J Clin Invest (2004) 1.19
Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth (2004) 1.18
A comparison of different techniques for liver resection: blunt dissection, ultrasonic aspirator and jet-cutter. Eur J Surg Oncol (1995) 1.11
QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis. Gene Ther (2009) 1.11
Colon interposition for esophageal replacement: an alternative technique based on the use of the right colon. Ann Surg (2000) 1.08
Preoperative risk assessment of hepatic resection for malignant disease. World J Surg (1997) 1.06
Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells. Oncogene (2009) 1.03
Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damage. Acta Physiol Scand (1985) 1.02
Jet-cutting supported by high frequency current: new technique for hepatic surgery. World J Surg (1997) 1.02
The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg (1997) 1.02
Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo. Br J Cancer (2000) 0.99
Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns. Clin Exp Metastasis (1998) 0.98
Liver retransplantation--indications, frequency, results. Transplant Proc (1992) 0.98
Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res (1990) 0.98
Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res (1997) 0.97
Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. J Clin Oncol (1995) 0.97
Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem (2000) 0.96
Posthypotensive generation of superoxide free radicals--possible role in the pathogenesis of the intestinal mucosal damage. Acta Chir Scand (1984) 0.96
Oxidative tissue damage following regional intestinal ischemia and reperfusion in the cat. Res Exp Med (Berl) (1984) 0.96
Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA? Dig Dis Sci (1999) 0.95
Laparoscopic liver resection with the water-jet dissector. Surg Endosc (1995) 0.95
Lower gastrointestinal bleeding: therapeutic strategies, surgical techniques and results. Langenbecks Arch Surg (2001) 0.94
Arterioportal fistula with portal hypertension after liver trauma and resection: a case report and review of the literature. Hepatogastroenterology (1998) 0.94
Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients. Anticancer Res (2002) 0.94
Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid. Gut (1992) 0.93
Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery (1992) 0.93
Conversion rate in 300 laparoscopic rectal resections and its influence on morbidity and oncological outcome. Int J Colorectal Dis (2008) 0.93
Laparoscopic mesh repair of incisional hernia: an alternative to the conventional open repair? Hernia (2007) 0.92
Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma (1993) 0.92
Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Physiol Cell Physiol (2000) 0.91
Impact of virtual reality imaging on hepatic liver tumor resection: calculation of risk. Langenbecks Arch Surg (2000) 0.91
Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum (2000) 0.91
Dynamic magnetic resonance imaging defecography: a diagnostic alternative in the assessment of pelvic floor disorders in proctology. Dis Colon Rectum (2001) 0.90
Microcirculatory failure after rat liver transplantation is related to Kupffer cell-derived oxidant stress but not involved in early graft dysfunction. Transplantation (2001) 0.90
Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg (1996) 0.90
[Endoscopic neodymium-yag laser irradiation for control of bleeding acute and chronic ulcers (author's transl)]. Langenbecks Arch Chir (1978) 0.90
Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sang (1997) 0.90